STEPHEN C. FARRELL - 24 Jun 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Samuel Gesten as attorney-in-fact for Stephen Farrell
Issuer symbol
STAA
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
4
Filing time
25 Jun 2021, 17:54:11 UTC
Previous filing
21 Jun 2021
Next filing
30 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +404 +7% $0.000000 6,212 24 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +850 $0.000000 850 24 Jun 2021 Common Stock 850 $154.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restrictions on the 404 restricted shares of common stock lapse on the earlier of June 24, 2022 or the Corporation's 2022 Annual Meeting, subject to Mr. Farrell's continued service through that date.
F2 The options vest on the earlier of June 24, 2022 or the Corporation's 2022 Annual Shareholders Meeting.

Remarks:

On June 24, 2021, STAAR Surgical Company granted Mr. Farrell, a non-employee director, 850 options to purchase common stock of the Corporation and 404 restricted shares of the Corporation's common stock on his re-election to the Board of Directors.